BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 38459407)

  • 1. Gene-edited cells: novel allogeneic gene/cell therapy for epidermolysis bullosa.
    Gila F; Alamdari-Palangi V; Rafiee M; Jokar A; Ehtiaty S; Dianatinasab A; Khatami SH; Taheri-Anganeh M; Movahedpour A; Fallahi J
    J Appl Genet; 2024 Mar; ():. PubMed ID: 38459407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem Cell Therapies for Epidermolysis Bullosa Treatment.
    Niti A; Koliakos G; Michopoulou A
    Bioengineering (Basel); 2023 Mar; 10(4):. PubMed ID: 37106609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Treatments for Epidermolysis Bullosa (EB): Emphasis on Stem Cell-Based Therapy.
    Raoufinia R; Rahimi HR; Keyhanvar N; Moghbeli M; Abdyazdani N; Rostami M; Naghipoor K; Forouzanfar F; Foroudi S; Saburi E
    Stem Cell Rev Rep; 2024 Jul; 20(5):1200-1212. PubMed ID: 38430362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Gene/Cell Therapy in Epidermolysis Bullosa.
    Murauer EM; Koller U; Pellegrini G; De Luca M; Bauer JW
    Keio J Med; 2015; 64(2):21-5. PubMed ID: 26050701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hereditary epidermolysis bullosa: updates and future prospects.
    Hsu CK; Wang SP; Lee JY; McGrath JA
    Am J Clin Dermatol; 2014 Feb; 15(1):1-6. PubMed ID: 24402870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Replacement Therapies for Genodermatoses: A
    Koller U; Bauer JW
    Front Genet; 2021; 12():658295. PubMed ID: 33995490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.
    Cutlar L; Greiser U; Wang W
    Exp Dermatol; 2014 Jan; 23(1):1-6. PubMed ID: 24107073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy approaches for epidermolysis bullosa.
    Ferrari S; Pellegrini G; Mavilio F; De Luca M
    Clin Dermatol; 2005; 23(4):430-6. PubMed ID: 16023940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newer Treatment Modalities in Epidermolysis Bullosa.
    Bruckner-Tuderman L
    Indian Dermatol Online J; 2019; 10(3):244-250. PubMed ID: 31149565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inside out: regenerative medicine for recessive dystrophic epidermolysis bullosa.
    Vanden Oever M; Twaroski K; Osborn MJ; Wagner JE; Tolar J
    Pediatr Res; 2018 Jan; 83(1-2):318-324. PubMed ID: 29593249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long and winding road that leads to a cure for epidermolysis bullosa.
    Carulli S; Contin R; De Rosa L; Pellegrini G; De Luca M
    Regen Med; 2013 Jul; 8(4):467-81. PubMed ID: 23826700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenetic Therapy of Epidermolysis Bullosa: Current State and Prospects.
    Ryumina II; Goryunov KV; Silachev DN; Shevtsova YA; Babenko VA; Marycheva NM; Kotalevskaya YY; Zubkov VV; Zubkov GT
    Bull Exp Biol Med; 2021 May; 171(1):109-121. PubMed ID: 34050833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigational Treatments for Epidermolysis Bullosa.
    Hou PC; Wang HT; Abhee S; Tu WT; McGrath JA; Hsu CK
    Am J Clin Dermatol; 2021 Nov; 22(6):801-817. PubMed ID: 34292508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a gene therapy clinical trial for epidermolysis bullosa.
    Ferrari S; Pellegrini G; Matsui T; Mavilio F; De Luca M
    Rev Recent Clin Trials; 2006 May; 1(2):155-62. PubMed ID: 18473966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hereditary epidermolysis bullosa: French national guidelines (PNDS) for diagnosis and treatment].
    Chiaverini C; Bourrat E; Mazereeuw-Hautier J; Hadj-Rabia S; Bodemer C; Lacour JP
    Ann Dermatol Venereol; 2017 Jan; 144(1):6-35. PubMed ID: 27931749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Prospects of Exon Skipping for Epidermolysis Bullosa.
    Vermeer FC; Bremer J; Sietsma RJ; Sandilands A; Hickerson RP; Bolling MC; Pasmooij AMG; Lemmink HH; Swertz MA; Knoers NVAM; van der Velde KJ; van den Akker PC
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current developments in gene therapy for epidermolysis bullosa.
    Kocher T; Petkovic I; Bischof J; Koller U
    Expert Opin Biol Ther; 2022 Sep; 22(9):1137-1150. PubMed ID: 35235467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa.
    So JY; Nazaroff J; Iwummadu CV; Harris N; Gorell ES; Fulchand S; Bailey I; McCarthy D; Siprashvili Z; Marinkovich MP; Tang JY; Chiou AS
    Orphanet J Rare Dis; 2022 Oct; 17(1):377. PubMed ID: 36253825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermolysis bullosa: Advances in research and treatment.
    Prodinger C; Reichelt J; Bauer JW; Laimer M
    Exp Dermatol; 2019 Oct; 28(10):1176-1189. PubMed ID: 31140655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging drugs for the treatment of epidermolysis bullosa.
    Titeux M; Bonnet des Claustres M; Izmiryan A; Ragot H; Hovnanian A
    Expert Opin Emerg Drugs; 2020 Dec; 25(4):467-489. PubMed ID: 33094671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.